Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.

Tatjana WelzelKlervi GolhenAndrew AtkinsonVerena GottaDavid TernantJasmin B Kuemmerle-DeschnerChristine MichlerGilbert KochJohannes N van den AnkerMarc PfisterAndreas Woerner

Published in: Pediatric rheumatology online journal (2024)

NCT04042792 , registered 02.08.2019.

Keyphrases

rheumatoid arthritis
juvenile idiopathic arthritis
ulcerative colitis
hidradenitis suppurativa
systemic lupus erythematosus
disease activity